Effect of Omega-3 Fatty Acid on Cortical Function in ADHD

Completed · Phase 3 · Has a placebo group

Conditions studied: Attention Deficit Disorder

In brief

The study hypothesis is that DHA is more effective than placebo in increasing brain activation and reducing symptoms in psychostimulant-free children with ADHD.

Key facts

Study ID

NCT01883817

Run by

University of Cincinnati

People needed

30

Starts

2013-09-01

Expected to finish

2017-03-03

Last updated by the study team

2022-03-16

Who can join

Age: 5 and older, up to 15. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Provision of written informed consent/assent
• Ages 5-15 years old
• Meets DSM-IV-TR criteria for ADHD as determined by the KSADS

You may not qualify if…

• Contraindication to an MRI scan (i.e., braces, claustrophobia)
• A history of a major medical (e.g., diabetes) or neurological illness (e.g., epilepsy)
• Greater than 1 year outside appropriate age/grade level
• A history of intolerance or hypersensitivity to omega-3 fatty acids
• Currently taking omega-3 supplements
• Not proficient in English language
• Any history of a hematological disorder or concomitant use of anticoagulant medications
• Personal history of an Axis I psychiatric disorder other than ADHD
• Inability to swallow capsules

Where it is running

• University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.